PROMO!First order? Get 10% OFF with this code: 1storder
PROMO!First order? Get 10% OFF with this code: 1storder
<ú<ø € EUR0.00 Cart
Home / CJC-1295 no DAC / Ipamorelin + CJC-1295 No DAC Pre-Mixed

Ipamorelin + CJC-1295 No DAC Pre-Mixed

The Ipamorelin and CJC-1295 No DAC blend synergistically stimulates natural growth hormone release, promoting muscle growth, fat loss, improved recovery, and anti-aging benefits.

Ipamorelin CJC-1295 No DAC Pre-mixed Pen kit contains: 1 x Ipamorelin CJC-1295 No DAC 2.5mg Cartridge (premixed with Bacteriostatic Water), 1 x Cartridge Pen with 3 Pen Needle Tips, plus a Pen Carry Case.

Single Ipamorelin CJC-1295 No DAC Pre-mixed Cartridges: Ipamorelin CJC-1295 No DAC 2.5mg 1, 2 or 3 x Cartridge (premixed with Bacteriostatic Water) plus 3 Pen Needle Tips. (Single mixed cartridges do not contain the pen or case).

Price: Price range: 0.00€ through 78.83€

 Guaranteed High Purity +99% Pure
 New Customer Discount (code: 1storder) Get 10% off your first order
Description

Buy Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide In Europe

 

Simplify your stack with Ipamorelin + CJC-1295 No DAC Pre-Mixed.
This ready-to-use 2-in-1 liquid peptide comes pre-blended and lab-verified so you can skip measuring and mixing. Every batch includes COA and ships from EU inventory for 48H delivery to UK, Germany, France and across Europe.

Customers buy Ipamorelin CJC-1295 No DAC pre-mixed for streamlined, consistent protocols. You can order Ipamorelin CJC-1295 liquid online and purchase pre-mixed 2-in-1 peptides with tracked EU shipping.

Looking to shop Ipamorelin CJC-1295 or stock up on pre-mixed peptide? We keep it in stock for fast, reliable service.
For laboratory use only. Not for human consumption.

 

Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide is a ready-to-use research formulation that combines Ipamorelin and CJC-1295 No DAC (also known as Modified GRF 1-29) in a single pre-mixed solution. Unlike lyophilized peptide products that require reconstitution, this formulation is supplied ready for laboratory handling according to the manufacturer’s instructions.

Ipamorelin is a selective growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHSR-1a), while CJC-1295 No DAC is a short-acting analogue of growth hormone-releasing hormone (GHRH). Because they stimulate growth hormone release through different biological pathways, they are frequently studied together in laboratory research. However, neither compound nor the combination has been approved by major regulatory authorities for routine therapeutic use. (Form Laboratories)


What Is Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide?

Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide is a manufacturer-prepared liquid formulation containing predetermined concentrations of Ipamorelin and CJC-1295 No DAC. The product is intended for research or other manufacturer-specified purposes and is supplied in a ready-to-use format.

Common characteristics include:

  • Ready-to-use liquid formulation
  • Combination of Ipamorelin and CJC-1295 No DAC
  • Manufacturer-labeled peptide concentrations
  • Quality-controlled manufacturing
  • Sterile packaging where applicable
  • Batch and lot identification
  • Available in various vial sizes depending on the manufacturer

Features of Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide

Key features may include:

  • Pre-mixed formulation requiring no reconstitution
  • Clearly labeled peptide concentrations
  • Secure sterile vial packaging
  • Quality-controlled production
  • Batch traceability
  • Manufacturer-specific storage recommendations
  • Available in multiple strengths depending on the supplier

Research Background of Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide

Ipamorelin is a synthetic pentapeptide that selectively activates the ghrelin receptor (GHSR-1a), promoting endogenous growth hormone release in experimental models. CJC-1295 No DAC, commonly referred to as Modified GRF (1-29), is a short-acting GHRH analogue designed to mimic the body’s natural pulsatile release of growth hormone-releasing hormone. Unlike the DAC version, the No DAC formulation has a much shorter duration of activity.

Researchers frequently investigate the combination because the two compounds act through complementary signaling pathways—one targeting the GHRH receptor and the other the ghrelin receptor. While this dual mechanism has generated scientific interest, evidence supporting clinical benefits remains limited, and additional well-controlled human studies are needed to establish long-term safety and effectiveness.


Potential Research Applications of Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide

Published scientific research involving these investigational compounds has explored:

  • Growth hormone physiology
  • Endocrine system research
  • Growth hormone secretagogue signaling
  • GHRH receptor biology
  • Metabolic research
  • Exercise physiology
  • Laboratory and scientific investigations

These applications remain investigational and should not be interpreted as approved medical indications.


Storage Guidelines for Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide

To help preserve product quality:

  • Store according to the manufacturer’s instructions.
  • Keep the vial in its original packaging.
  • Protect from excessive heat, moisture, and direct sunlight.
  • Refrigerate if recommended by the manufacturer.
  • Do not freeze unless specifically instructed.
  • Do not use if the vial is damaged or leaking.
  • Keep out of the reach of children.

Always follow the storage recommendations supplied with the product.


Safety Information for Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide

Important precautions include:

  • Use only according to the manufacturer’s labeling.
  • Handle using appropriate laboratory procedures.
  • Do not use if contamination is suspected or the seal has been broken.
  • Follow recommended storage conditions.
  • Consult qualified professionals regarding appropriate laboratory handling.

Both Ipamorelin and CJC-1295 No DAC remain investigational compounds. Their safety and effectiveness for routine therapeutic use have not been established by major regulatory authorities.


Disposal of Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide

After use or when expired:

  • Dispose of the product according to local regulations.
  • Do not reuse single-use containers.
  • Discard damaged or expired vials appropriately.
  • Follow institutional procedures for laboratory or pharmaceutical waste disposal.

Frequently Asked Questions About Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide

What is Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide?

Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide is a ready-to-use research formulation containing Ipamorelin and CJC-1295 No DAC (Modified GRF 1-29) in a single preparation for laboratory or manufacturer-specified applications. (Form Laboratories)

What is Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide used for?

Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide is intended for scientific research involving growth hormone physiology, endocrine signaling, and metabolic biology. It is not approved for routine medical treatment. (Form Laboratories)

How should Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide be stored?

Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide should be stored according to the manufacturer’s recommendations, which may include refrigeration and protection from excessive heat, moisture, and direct sunlight.

 


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: Products are supplied for research purposes only and are not intended to diagnose, treat, cure, or prevent any disease.